These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 18298458)

  • 21. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Progress in the Development of New Antimalarial Drugs with Novel Targets.
    Belete TM
    Drug Des Devel Ther; 2020; 14():3875-3889. PubMed ID: 33061294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential and limits of in silico target discovery - Case study of the search for new antimalarial chemotherapeutic targets.
    Saïdani N; Grando D; Valadié H; Bastien O; Maréchal E
    Infect Genet Evol; 2009 May; 9(3):359-67. PubMed ID: 18294927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malarial kinases: novel targets for in silico approaches to drug discovery.
    Bullard KM; DeLisle RK; Keenan SM
    Methods Mol Biol; 2013; 993():205-29. PubMed ID: 23568473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone as future drug target for malaria.
    Rawat DS; Lumb V; Sharma YD; Pasha ST; Singh G
    J Commun Dis; 2007 Jun; 39(2):119-28. PubMed ID: 18338692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
    Fattorusso C; Campiani G; Kukreja G; Persico M; Butini S; Romano MP; Altarelli M; Ros S; Brindisi M; Savini L; Novellino E; Nacci V; Fattorusso E; Parapini S; Basilico N; Taramelli D; Yardley V; Croft S; Borriello M; Gemma S
    J Med Chem; 2008 Mar; 51(5):1333-43. PubMed ID: 18278859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimalarial dosing regimens and drug resistance.
    Barnes KI; Watkins WM; White NJ
    Trends Parasitol; 2008 Mar; 24(3):127-34. PubMed ID: 18262470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel antiplasmodial agents.
    Go ML
    Med Res Rev; 2003 Jul; 23(4):456-87. PubMed ID: 12710020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current antimalarial drugs: resistance and new strategies].
    Ringwald P
    Bull Acad Natl Med; 2007 Oct; 191(7):1273-84; discussion 1284. PubMed ID: 18447049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Old and new targets for innovative antimalarial compounds: the different strategies of the Italian Malaria Network.
    Basilico N; Bosisio E; Buelli F; Campiani G; Casagrande M; Castelli F; Coghi P; Corbett Y; Cortelezzi L; D'Alessandro S; Dell'Agli M; Esposito F; Fattorusso C; Fattorusso E; Finaurini S; Galli GV; Gemma S; Habluetzel A; Lucantoni L; Melato S; Monti D; Olliaro P; Omodeo-Salè F; Parapini S; Persico M; Rizzi M; Romeo S; Rossi F; Rusconi C; Sparatore A; Scafati OT; van den Bogaart E; Taramelli D; Vaiana N; Yerbanga S
    Parassitologia; 2008 Jun; 50(1-2):133-6. PubMed ID: 18693579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host-cell invasion by malaria parasites: insights from Plasmodium and Toxoplasma.
    Baum J; Gilberger TW; Frischknecht F; Meissner M
    Trends Parasitol; 2008 Dec; 24(12):557-63. PubMed ID: 18835222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel approaches to antimalarial drug discovery.
    Biot C; Chibale K
    Infect Disord Drug Targets; 2006 Jun; 6(2):173-204. PubMed ID: 16789878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarials from nature.
    Kaur K; Jain M; Kaur T; Jain R
    Bioorg Med Chem; 2009 May; 17(9):3229-56. PubMed ID: 19299148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in naturally derived antimalarials: cryptolepine analogues.
    Wright CW
    J Pharm Pharmacol; 2007 Jun; 59(6):899-904. PubMed ID: 17637183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artemisia annua as a self-reliant treatment for malaria in developing countries.
    de Ridder S; van der Kooy F; Verpoorte R
    J Ethnopharmacol; 2008 Dec; 120(3):302-14. PubMed ID: 18977424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinoline-based antimalarial hybrid compounds.
    Vandekerckhove S; D'hooghe M
    Bioorg Med Chem; 2015 Aug; 23(16):5098-119. PubMed ID: 25593097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New methodologic approaches in antimalarial molecular research].
    Gozalbes R; Mahmoudi N; Mazier D; Danis M; Derouin F
    Med Trop (Mars); 2004; 64(1):66-70. PubMed ID: 15224562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
    Babiker HA; Hastings IM; Swedberg G
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):581-93. PubMed ID: 19485798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The future outlook of antimalarials].
    Millet P
    Rev Prat; 2005 Apr; 55(8):875-9. PubMed ID: 15999841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.